Trademark Overview
On Monday, December 30, 2024, a trademark application was filed for RESOLVE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RESOLVE THERAPEUTICS trademark a serial number of 98928125. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, June 12, 2025. This trademark is owned by Resolve Therapeutics LLC. The RESOLVE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical information services provided via the Internet; Providing medical information; Providing medical information in the field of pharmaceuticals, medicines, autoimmune diseases, and immune-cardiology; Providing medical information in the field of healthcare, health conditions, and diseases
Biological research; Biological research and analysis; Medical research; Medical research laboratories; Medical research laboratory services; Medical research services; Medical and scientific research in the field of autoimmune diseases, immuno-cardiology, chronic inflammations, heart diseases, and new therapies for autoimmune diseases.; Providing information about medical and scientific research via a website; Research and development of new products for others; Research and development in the field of autoimmune diseases, immuno-cardiology, chronic inflammations, heart diseases, and new therapies for autoimmune diseases.; Research and development services in the field of medical preparations; Technological research in the field of autoimmune and inflammatory diseases, cardiovascular diseases and infectious diseases; Pathological testing for medical research purposes; Providing medical research information in the field of pharmaceuticals; Providing medical and scientific research info...
